The Impact of Botox® During Robotic Rehabilitation of the Wrist Following Stroke
NCT01088230 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 12
Last updated 2011-04-26
Summary
The purpose of this study is to see whether treating subjects for wrist rehabilitation following stroke with Botox® and robotic therapy is more effective than treatment with robotic therapy alone and no Botox®.
Conditions
Interventions
- OTHER
-
Botox®
the treatment group will receive a one time injection of Botox® at the wrist flexors and pronators of the affected arm. Each subject will receive a standard dose of 150 units total, 50u each to the flexor carpi radialis and flexor carpi ulnaris, and 25u each for the pronator teres and pronator quadratus muscle groups.
- OTHER
-
saline solution
the control group will receive a one time injection of salt water in the flexor carpi radialis and flexor carpi ulnaris, and the pronator teres and pronator quadratus muscle groups.
Sponsors & Collaborators
-
New York Presbyterian Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-06-30
- Primary Completion
- 2010-09-30
- Completion
- 2010-11-30
Countries
- United States
Study Locations
More Related Trials
-
A Multicenter, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Upper Limb Spasticity
NCT01153815 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity
NCT00661089 ·Status: COMPLETED ·Phase: NA
-
BOTOX® Versus Zanaflex® for the Treatment of Post-Stroke or Traumatic Brain Injury Upper Limb Spasticity
NCT00430196 ·Status: COMPLETED ·Phase: PHASE4
-
Hand Rehabilitation Using Botulinum Toxin and Functional Electrical Stimulation-pilot Study
NCT03549975 ·Status: COMPLETED ·Phase: PHASE4
-
Upper Extremity Rehabilitation Using Robot and Botulinum Toxin
NCT02228863 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function
NCT00076687 ·Status: COMPLETED ·Phase: PHASE2
-
Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke
NCT01910363 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
A Study to Evaluate the Botulinum Toxin Type A for Injection(HengLi®) in Subjects With Post-stroke Upper Limb Spasticity
NCT02280083 ·Status: COMPLETED ·Phase: PHASE3
-
The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity
NCT05887479 ·Status: WITHDRAWN ·Phase: PHASE4
-
BOTOX® (Onabotulinumtoxin A) Injection(s) as a Treatment for Carpal Tunnel Syndrome
NCT02070302 ·Status: COMPLETED ·Phase: PHASE2
-
The Effects of Early and Late Injection of Botulinum Toxin Type A on Upper Limb Function in Patients With Stroke
NCT02580838 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
NCT00945295 ·Status: COMPLETED ·Phase: NA
-
Study of Responsiveness of Seven Functional Tasks in Patients With Poststroke Upper Limb Spasticity With Botulinum Toxin Type A Treatment
NCT00651690 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Botulinum Toxin Type A Against Placebo to Treat Spasticity in the Leg After a Stroke
NCT01464307 ·Status: COMPLETED ·Phase: PHASE3
-
Optimal Dose of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity
NCT02358005 ·Status: UNKNOWN ·Phase: PHASE4
-
The Effect of Extracorporeal Shock Wave Therapy After Botulinum Toxin Type A Injection for Post-stroke Spasticity
NCT05889026 ·Status: COMPLETED ·Phase: NA
-
Early Botulinum Toxin for Muscle Stiffness Reduction in First-Time Stroke Patients: Improving Recovery and Independence
NCT06811142 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Botulinum Toxin as a Novel Treatment for Prevention of Post-Traumatic Elbow Stiffness
NCT01129583 ·Status: COMPLETED ·Phase: NA
-
A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity
NCT01205451 ·Status: COMPLETED ·Phase: PHASE3
-
Early Injection of Botulinum Toxin on Motor Function and Gait Pattern in Stroke Patients
NCT01817816 ·Status: COMPLETED ·Phase: NA
-
Phase III Study of Botulax® to Treat Post Stroke Upper Limb Spasticity
NCT01915459 ·Status: COMPLETED ·Phase: PHASE3
-
Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Lower Extremities
NCT02469948 ·Status: UNKNOWN ·Phase: PHASE3
-
Botulinim Toxin Type A Injections by Different Guidance in Stroke Patients With Spasticity on Upper Extremities
NCT02557737 ·Status: UNKNOWN ·Phase: PHASE3
-
Randomised, Evaluation-blinded, Crossover, Controlled Study Assessing Dynamic Hand Splinting in Adults With Post-stroke Hemiplegia (Orthox)
NCT02888548 ·Status: TERMINATED ·Phase: NA
-
Safety and Effectiveness of Botulinum Toxin in Elderly Patients With Dementia and Muscle Stiffness
NCT02212119 ·Status: COMPLETED ·Phase: PHASE2